Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis.

by Steffie K Naber, Suzette M Matthijsse, Kirsten Rozemeijer, Corine Penning, Inge M C M de Kok, Marjolein van Ballegooijen
Published 2016-01-01

Investigating the decrease in participation in the Dutch cervical cancer screening programme: The role of personal and organisational characteristics

by Clare A. Aitken, Sylvia Kaljouw, Albert G. Siebers, Matilde Bron, Anne Morssink, Folkert J. van Kemenade, Inge M.C.M. de Kok
Published 2021-06-01

The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model.

by Suzette M Matthijsse, Joost van Rosmalen, Jan A C Hontelez, Roel Bakker, Inge M C M de Kok, Marjolein van Ballegooijen, Sake J de Vlas
Published 2015-01-01

The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study.

by Suzette M Matthijsse, Steffie K Naber, Jan A C Hontelez, Roel Bakker, Marjolein van Ballegooijen, Iris Lansdorp-Vogelaar, Inge M C M de Kok, Harry J de Koning, Joost van Rosmalen, Sake J de Vlas
Published 2018-01-01

Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study

by Clare A. Aitken, Heleen M. E. van Agt, Albert G. Siebers, Folkert J. van Kemenade, Hubert G. M. Niesters, Willem J. G. Melchers, Judith E. M. Vedder, Rob Schuurman, Adriaan J. C. van den Brule, Hans C. van der Linden, John W. J. Hinrichs, Anco Molijn, Klaas J. Hoogduin, Bettien M. van Hemel, Inge M. C. M. de Kok
Published 2019-12-01